All Stories

  1. Immune responses against tumour-associated antigen-derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients

    Article • Liver International, July 2018, Wiley

    Takeshi Terashima

  2. Analysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapy

    Article • Hepatology Research, June 2018, Wiley

    Takeshi Terashima

  3. Beneficial Effect of Maintaining Hepatic Reserve during Chemotherapy on the Outcomes of Patients with Hepatocellular Carcinoma

    Article • Liver Cancer, January 2017, Karger Publishers

    Takeshi Terashima

  4. Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis

    Article • Cancer Science, September 2016, Wiley

    Takeshi Terashima

  5. Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma

    Article • BMC Cancer, May 2016, Springer Science + Business Media

    Takeshi Terashima

  6. Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib

    Article • Hepatology Research, November 2015, Wiley

    Takeshi Terashima

  7. Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy

    Article • Hepatology Research, November 2014, Wiley

    Takeshi Terashima

  8. P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma

    Article • Cancer Immunology Immunotherapy, March 2014, Springer Science + Business Media

    Takeshi Terashima

  9. Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib

    Article • Hepatology Research, January 2014, Wiley

    Takeshi Terashima

  10. Extrapulmonary neuroendocrine tumors: An institutional experience of 337 patients at the National Cancer Center Hospital in Japan.

    Article • Journal of Clinical Oncology, February 2011, American Society of Clinical Oncology (ASCO)

    Takeshi Terashima